Acreage Holdings Inc’s ACRGF first-quarter results showed improved operating trends, and the company exited the quarter with lower liquidity risks, according to Cantor Fitzgerald.
The Acreage Analyst
Pablo Zuanic maintained a Neutral rating on Acreage Holdings and raised the price target from $2.30 to $2.90.
The Acreage Thesis
Acreage achieved 15% sequential sales growth in the March quarter, with master service agreement units generating 20% revenue growth and the company’s gross margins expanding by four percentage points, all of which are “good metrics,” Zuanic said in a Friday note. (See his track record here.)
Although Acreage’s performance in the second quarter will be impacted by COVID-19-related closures of some of its facilities and dispensaries, the cannabis company seemed confident of reaching positive EBITDA for the year, the analyst said.
Referring to the risk of insolvency, Zuanic said the company exited March with $40 million in cash; is making efforts to resize the business; and should be able to raise about $80 million from an equity offering, which has already been agreed upon as part of the revised terms of its contingent deal with Canopy Growth CGC.
Given these factors, “we now take a 50% discount (to the Canopy Growth contingent deal offer price) to value Acreage vs. 60% before,” the analyst said.
ACRGF Price Action
Shares of Acreage Holdings were down 9.03% at $2.62 at the time of publication Friday.
Related Links:
Canopy Continues To Expand, Amends $37.5M Deal Agreement With Acreage
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.